Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on April 2, 2025
Top Landmarks Around The World to Spark The Night Blue for Parkinson's Awareness
EIN Presswire
·
April 2, 2025
500+ Top Landmarks Around the World to Spark Blue for Parkinson’s Awareness on April 11 VANCOUVER, BC, CANADA, April 2, 2025 /EINPresswire.com/ -- In an inspiring show of solidarity, some of the world’s most iconic landmarks are set to illuminate in …
COAF Launches Appeal to Build Sports Complex for Children in Rural Armenia
EIN Presswire
·
April 2, 2025
The Children of Armenia Fund (COAF) will raise $200,000 to provide over 1,600 children weekly with a modern space for sports and play. YEREVAN, YEREVAN, ARMENIA, April 2, 2025 /EINPresswire.com/ -- The Children of Armenia Fund (COAF) has officially …
INFLO, a Leading Medical Tourism Platform, Partners with 70+ Plastic Surgery and Dermatology Clinics in Korea
EIN Presswire
·
April 2, 2025
INFLO partners with 70+ top plastic surgery and dermatology clinics in Korea, providing international patients with direct access to trusted medical services. LOS ANGELES, CA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- INFLO, a rapidly growing …
Join us for The Son-Rise Program® In-Person Start-Up
EIN Presswire
·
April 2, 2025
Autism Treatment Center of America® announces The Son-Rise Program® In-Person Start-Up in Sheffield, Massachusetts, June 23rd - 27th. SHEFFIELD, MA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- The Son-Rise Program, a transformative approach to …
Robotimize and Rehabotics Forge Strategic Alliance in Neurorehabilitation with Global Relaunch of MirrorHand Exoskeleton
EIN Presswire
·
April 2, 2025
Merging advanced robotics and clinical expertise to redefine neurorehabilitation and relaunch the HandVivante™ MirrorHand system. SINGAPORE, April 2, 2025 /EINPresswire.com/ -- Robotimize Group, a global leader in neurorehabilitation robotics, and …
YTHDF1 Identified As a Potential Therapeutic Target for Autoimmune Hepatitis
EIN Presswire
·
April 2, 2025
New Study Underscores The Pivotal Role Of YTHDF1 In Immune-Mediated Hepatitis CHINA, April 2, 2025 /EINPresswire.com/ -- Autoimmune hepatitis (AIH) is a severe autoimmune disease characterized by immune-mediated hepatocyte destruction, leading to …
Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its plans to meet with the United States Food and Drug Administration (FDA) …
Amanda Cowlrick Inducted into the Prestigious International Order of Fantastic Professionals
EIN Presswire
·
April 2, 2025
EDMONTON, ALBERTA, CANADA, April 2, 2025 /EINPresswire.com/ -- Amanda Cowlrick is the founder of Replenish Healing®, a holistic healing company based in Auckland, New Zealand. A passionate advocate for natural healing, Amanda is a Homeopath, Reiki Master …
America’s VetDogs Supports Introduction of the Service Dogs Assisting Veterans Act
GlobeNewswire
·
April 2, 2025
Washington, DC, and Smithtown, NY, April 02, 2025 (GLOBE NEWSWIRE) -- America's VetDogs, a leading national nonprofit provider of service dogs to veterans, active-duty service members, and first responders with disabilities, today joined Congressman Morgan …
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
AUSTIN, TX and DURHAM, NC, April 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the …
A' Accessibility, Assistive Technologies, and Inclusive Design Award Announces Final Call for Entries
EIN Presswire
·
April 2, 2025
The prestigious A' Accessibility, Assistive Technologies, and Inclusive Design Award extends final submission opportunity until April 7, 2025 COMO, CO, ITALY, April 2, 2025 /EINPresswire.com/ -- The A' Accessibility, Assistive Technologies, and …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Range Impact Announces Major Land Acquisition in West Virginia
GlobeNewswire
·
April 2, 2025
CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mines throughout Appalachia, today announced the …
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
·
April 2, 2025
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancer Disciplined financial strategy toward long- …
NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers de l’exercice 2024
GlobeNewswire
·
April 2, 2025
Le programme de développement global de JNJ-1900 (NBTXR3) progresse comme prévu, avec l’opportunité d’adresser l’un des plus grands marchés inexploités en oncologie grâce aux programmes les plus avancés dans le cancer de la tête et du cou et le cancer du …
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
GlobeNewswire
·
April 2, 2025
Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus on developing commercial opportunities, spin-outs, joint- …
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
GlobeNewswire
·
April 2, 2025
PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange …
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
GlobeNewswire
·
April 2, 2025
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …